Targeted Cancer Therapy: Two New Breakthrough Approaches
Next-Gen Cancer Warfare: Sidewinder Therapeutics and Stipple Bio Secure Massive Funding to Revolutionize Antibody-Drug Conjugates NEW YORK — The landscape of precision oncology is shifting as two biotech trailblazers, Sidewinder Therapeutics and Stipple Bio, have each secured “mega-rounds” of financing. This influx of capital is earmarked for a singular, ambitious goal: perfecting the targeting mechanisms … Read more